Terumo India introduces advanced liver cancer treatments Occlusafe and LifePearl

Pallavi Madhiraju- November 11, 2023 0

Terumo India, the Indian subsidiary of the globally recognized Terumo Corporation, has recently announced the launch of two innovative products, Occlusafe and LifePearl, aimed at ... Read More

Your diet soda could be deadly: What international agencies say about Aspartame

Pallavi Madhiraju- July 14, 2023 0

the International Agency for Research on Cancer (IARC) and the Joint Expert Committee on Food Additives (JECFA), of the World Health Organization (WHO) and the ... Read More

AstraZeneca’s IMFINZI/IMJUDO shows sustained OS in Phase 3 liver cancer study

Pallavi Madhiraju- June 29, 2023 0

AstraZeneca's IMFINZI (durvalumab) combined with IMJUDO (tremelimumab-actl) has demonstrated an enduring overall survival (OS) benefit in patients with advanced hepatocellular carcinoma (HCC), according to the ... Read More

SillaJen and Lee’s Pharmaceutical launch Phase 3 trial of Pexa-Vec in China for advanced liver cancer

pharmanewsdaily- September 5, 2018 0

In a significant development in the fight against liver cancer, South Korean biotech company SillaJen, in partnership with Hong Kong-based Lee's Pharmaceutical, has announced the ... Read More